03.18.08
Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs to treat cancer, inflammatory diseases and pain. He reports to John Yates, M.D., chief medical officer.
“We are very pleased to have someone of Gary’s caliber leading our biostatistics group,” said Dr. Yates. “Gary’s expertise in advancing cancer therapeutics, including Tarceva, will be a competitive advantage for Array as we progress our six wholly-owned drugs in human clinical development.”
Prior to joining the company, Dr. Clark spent six years at OSI Pharmaceuticals serving as vice president of biostatistics and data management, where he successfully supported the approval of Tarceva for the treatment of patients with advanced non-small cell lung cancer and for patients with advanced pancreatic cancer. Prior to that, Dr. Clark served three years at Baylor College of Medicine as associate director of the breast center and professor of medicine. Dr. Clark's previous positions included professor of medicine, department of medicine/oncology at the University of Texas Health Science Center at San Antonio, director of the biostatistics, data processing and data management shared resource of the San Antonio Cancer Institute, and associate professor, department of biometry, University of Kansas Medical Center.
“We are very pleased to have someone of Gary’s caliber leading our biostatistics group,” said Dr. Yates. “Gary’s expertise in advancing cancer therapeutics, including Tarceva, will be a competitive advantage for Array as we progress our six wholly-owned drugs in human clinical development.”
Prior to joining the company, Dr. Clark spent six years at OSI Pharmaceuticals serving as vice president of biostatistics and data management, where he successfully supported the approval of Tarceva for the treatment of patients with advanced non-small cell lung cancer and for patients with advanced pancreatic cancer. Prior to that, Dr. Clark served three years at Baylor College of Medicine as associate director of the breast center and professor of medicine. Dr. Clark's previous positions included professor of medicine, department of medicine/oncology at the University of Texas Health Science Center at San Antonio, director of the biostatistics, data processing and data management shared resource of the San Antonio Cancer Institute, and associate professor, department of biometry, University of Kansas Medical Center.